These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34134627)

  • 1. Transcriptomics of type 2 diabetic and healthy human neutrophils.
    Kleinstein SE; McCorrison J; Ahmed A; Hasturk H; Van Dyke TE; Freire M
    BMC Immunol; 2021 Jun; 22(1):37. PubMed ID: 34134627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes.
    Freire MO; Dalli J; Serhan CN; Van Dyke TE
    J Immunol; 2017 Jan; 198(2):718-728. PubMed ID: 27994073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes.
    Herrera BS; Hasturk H; Kantarci A; Freire MO; Nguyen O; Kansal S; Van Dyke TE
    Infect Immun; 2015 Feb; 83(2):792-801. PubMed ID: 25486994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes.
    Sima C; Paster B; Van Dyke TE
    Crit Rev Immunol; 2018; 38(5):343-365. PubMed ID: 30806214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease.
    Barden AE; Shinde S; Burke V; Puddey IB; Beilin LJ; Irish AB; Watts GF; Mori TA
    Prostaglandins Other Lipid Mediat; 2018 May; 136():1-8. PubMed ID: 29577973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation.
    El Kebir D; Gjorstrup P; Filep JG
    Proc Natl Acad Sci U S A; 2012 Sep; 109(37):14983-8. PubMed ID: 22927428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proresolving Mediators LXB4 and RvE1 Regulate Inflammation in Stromal Cells from Patients with Shoulder Tendon Tears.
    Dakin SG; Colas RA; Wheway K; Watkins B; Appleton L; Rees J; Gwilym S; Little C; Dalli J; Carr AJ
    Am J Pathol; 2019 Nov; 189(11):2258-2268. PubMed ID: 31437425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolvin E1 receptor activation signals phosphorylation and phagocytosis.
    Ohira T; Arita M; Omori K; Recchiuti A; Van Dyke TE; Serhan CN
    J Biol Chem; 2010 Jan; 285(5):3451-61. PubMed ID: 19906641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution.
    Campbell EL; Louis NA; Tomassetti SE; Canny GO; Arita M; Serhan CN; Colgan SP
    FASEB J; 2007 Oct; 21(12):3162-70. PubMed ID: 17496159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal Peripheral Neutrophil Transcriptome in Newly Diagnosed Type 2 Diabetes Patients.
    Lin Q; Zhou W; Wang Y; Huang J; Hui X; Zhou Z; Xiao Y
    J Diabetes Res; 2020; 2020():9519072. PubMed ID: 32377527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators.
    Jin Y; Arita M; Zhang Q; Saban DR; Chauhan SK; Chiang N; Serhan CN; Dana R
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4743-52. PubMed ID: 19407006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets.
    Dona M; Fredman G; Schwab JM; Chiang N; Arita M; Goodarzi A; Cheng G; von Andrian UH; Serhan CN
    Blood; 2008 Aug; 112(3):848-55. PubMed ID: 18480426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole blood co-expression modules associate with metabolic traits and type 2 diabetes: an IMI-DIRECT study.
    Gudmundsdottir V; Pedersen HK; Mazzoni G; Allin KH; Artati A; Beulens JW; Banasik K; Brorsson C; Cederberg H; Chabanova E; De Masi F; Elders PJ; Forgie I; Giordano GN; Grallert H; Gupta R; Haid M; Hansen T; Hansen TH; Hattersley AT; Heggie A; Hong MG; Jones AG; Koivula R; Kokkola T; Laakso M; Løngreen P; Mahajan A; Mari A; McDonald TJ; McEvoy D; Musholt PB; Pavo I; Prehn C; Ruetten H; Ridderstråle M; Rutters F; Sharma S; Slieker RC; Syed A; Tajes JF; Thomas CE; Thomsen HS; Vangipurapu J; Vestergaard H; Viñuela A; Wesolowska-Andersen A; Walker M; Adamski J; Schwenk JM; McCarthy MI; Pearson E; Dermitzakis E; Franks PW; Pedersen O; Brunak S
    Genome Med; 2020 Dec; 12(1):109. PubMed ID: 33261667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of polyunsaturated ω-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) in bone preservation.
    Gyurko R; Van Dyke TE
    Crit Rev Immunol; 2014; 34(4):347-57. PubMed ID: 24941160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of weight loss on neutrophil resolvins in the metabolic syndrome.
    Barden A; Shinde S; Tsai IJ; Croft KD; Beilin LJ; Puddey IB; Mori TA
    Prostaglandins Leukot Essent Fatty Acids; 2019 Sep; 148():25-29. PubMed ID: 31492430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin.
    Salic K; Morrison MC; Verschuren L; Wielinga PY; Wu L; Kleemann R; Gjorstrup P; Kooistra T
    Atherosclerosis; 2016 Jul; 250():158-65. PubMed ID: 27236706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolvin E1 metabolome in local inactivation during inflammation-resolution.
    Hong S; Porter TF; Lu Y; Oh SF; Pillai PS; Serhan CN
    J Immunol; 2008 Mar; 180(5):3512-9. PubMed ID: 18292578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions.
    Arita M; Oh SF; Chonan T; Hong S; Elangovan S; Sun YP; Uddin J; Petasis NA; Serhan CN
    J Biol Chem; 2006 Aug; 281(32):22847-54. PubMed ID: 16757471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation.
    Oh SF; Pillai PS; Recchiuti A; Yang R; Serhan CN
    J Clin Invest; 2011 Feb; 121(2):569-81. PubMed ID: 21206090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1.
    Arita M; Bianchini F; Aliberti J; Sher A; Chiang N; Hong S; Yang R; Petasis NA; Serhan CN
    J Exp Med; 2005 Mar; 201(5):713-22. PubMed ID: 15753205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.